# Ixazomib, Cyclophosphamide and Dexamethasone for Multiple Myeloma

> **NCT02412228** · PHASE2 · COMPLETED · sponsor: **John L. Reagan** · enrollment: 12 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Ixazomib
- **DRUG:** Cyclophosphamide
- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT02412228
- **Lead sponsor:** John L. Reagan
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2019-03-29
- **Final completion:** 2023-11-09
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2025-10-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02412228

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02412228, "Ixazomib, Cyclophosphamide and Dexamethasone for Multiple Myeloma". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02412228. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*